Rush to Study Epigenetics of Cognitive Decline | GenomeWeb

NEW YORK (GenomeWeb News) – Rush University Medical Center in Chicago plans to use $5.5 million in grant funding from The National Institutes of Health to study how epigenetic changes may contribute to cognitive decline in older people, Rush said Wednesday.

Rush will conduct epigenome-wide DNA methylation scans and histone acetylation scans on brain tissue from participants in longitudinal studies of aging and dementia, including the Rush Memory and Aging Project and the Religious Orders Study.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.